Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2523
Source ID: NCT01521962
Associated Drug: Alogliptin
Title: Study of Combination Therapy With SYR-322
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus
Interventions: DRUG: Alogliptin|DRUG: Insulin
Outcome Measures: Primary: Change in glycosylated hemoglobin (HbA1c; Japan Diabetes Society value), Baseline and Week 12 |
Sponsor/Collaborators: Sponsor: Takeda
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 67
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: |Primary Purpose:
Start Date: 2012-02
Completion Date: 2013-03
Results First Posted:
Last Update Posted: 2013-11-13
Locations: Aomori-shi, Aomori, Japan|Hirosaki-shi, Aomori, Japan|Kashiwa-shi, Chiba, Japan|Kisarazu-shi, Chiba, Japan|Kitakyushu-shi, Fukuoka, Japan|Aki-gun, Hiroshima, Japan|Fukuyama-shi, Hiroshima, Japan|Nishinomiya-shi, Hyogo, Japan|Koga-shi, Ibaraki, Japan|Ushiku-shi, Ibaraki, Japan|Kahoku-gun, Ishikawa, Japan|Hanamaki-shi, Iwate, Japan|Morioka-shi, Iwate, Japan|Kagoshima-shi, Kagoshima, Japan|Satsuma-sendai-shi, Kagoshima, Japan|Kumamoto-shi, Kumamoto, Japan|Minamata-shi, Kumamoto, Japan|Miyazaki-shi, Miyazaki, Japan|Nigata-shi, Nigata, Japan|Hirakata-shi, Osaka, Japan|Osaka-sayama-shi, Osaka, Japan|Osaka-shi, Osaka, Japan|Takatsuki-shi, Osaka, Japan|Yao-shi, Osaka, Japan|Kuki-shi, Saitama, Japan|Otsu-shi, Shiga, Japan|Hamamatsu-shi, Shizuoka, Japan|Shizuoka-shi, Shizuoka, Japan|Shimotsuke-shi, Tochigi, Japan|Shinagawa-ku, Tokyo, Japan|Toyama-shi, Toyama, Japan|Sagae-shi, Yamagata, Japan|Yamagata-shi, Yamagata, Japan
URL: https://clinicaltrials.gov/show/NCT01521962

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress